BIOMAT Database Logo BIOMAT Database Logo

MHC class II and negative regulators of hematopoiesis. 1998

H J Deeg, and V Lesnikov
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

HLA-DR antigens a side from their antigen-presenting function have recently been shown to allow for transmembrane signaling. Findings in several models suggest that such a signaling function may occur in hematopoietic tissues. Signals generated via HLA-DR result in upregulation of tumor necrosis factor alpha (TNF-alpha) and nitric oxide as well as an enhanced expression of Fas and its natural ligand (Fas-L), all molecules associated with programmed cell death (apoptosis). While a role of HLA-DR in hematopoietic failure remains hypothetical, the data presented here can be accommodated into a model of hematopoietic failure initiated by HLA-DR mediated signals.

UI MeSH Term Description Entries
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

H J Deeg, and V Lesnikov
Negative regulators of hematopoiesis.
January 1984, Kroc Foundation series,
H J Deeg, and V Lesnikov
Complementation cloning of mammalian transcriptional regulators: the example of MHC class II gene regulators.
October 1995, Current opinion in genetics & development,
H J Deeg, and V Lesnikov
Negative regulation of MHC class II gene expression by CXCR4.
August 2006, Experimental hematology,
H J Deeg, and V Lesnikov
Summary of Meeting on Negative Regulators of Hematopoiesis.
February 1991, Experimental hematology,
H J Deeg, and V Lesnikov
Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules.
January 2009, Methods in molecular biology (Clifton, N.J.),
H J Deeg, and V Lesnikov
MHC class I and class II structures.
February 1997, Current opinion in immunology,
H J Deeg, and V Lesnikov
Serum-derived MHC class II molecules: potent regulators of the cellular and humoral immune response.
March 2010, Immunobiology,
H J Deeg, and V Lesnikov
MHC class II tetramers.
March 2012, Journal of immunology (Baltimore, Md. : 1950),
H J Deeg, and V Lesnikov
Present Yourself! By MHC Class I and MHC Class II Molecules.
November 2016, Trends in immunology,
H J Deeg, and V Lesnikov
Major histocompatibility complex (MHC) class II--positive dendritic cells in the rat iris. In situ development from MHC class II-negative precursors.
November 1997, Investigative ophthalmology & visual science,
Copied contents to your clipboard!